MedPath

Comparison of intravenous dexmedetomidine and clonidine effect in Trans-ABdominal Hysterectomy undergoing in spinal anaesthesia given by bupivacaine

Not yet recruiting
Conditions
Multigravida
Registration Number
CTRI/2018/07/014690
Lead Sponsor
RNT Medical College
Brief Summary

This is a Randomized, prospective double blind placebo control study to evaluate the effect of intravenous Dexmedetomidine and clonidine on the characteristics of subarachnoid block by Bupivacaine in Trans-Abdominal Hysterectomy.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
150
Inclusion Criteria

ASA grade I and grade II.

Exclusion Criteria

ASA grade III or above BMI > 30kg/m2 Who will refuse to give consent for spinal anaesthesia History of cardiac rhythm like bradycardia or A-V junction bkock History of preoperative intake of ACE inhibitors, calcium channel blockers, beta blockers, alpha 2 adrenergic receptor antagonist.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate of the effect of Intravenous Dexmedetomidine and Clonidine on the characteristics of Subarachnoid block by Bupivacaine in Trans-Abdominal Hysterectomy1min, 2mins, 5mins, 10mins, 15mins, 30mins, 45mins, till end of surgery
Secondary Outcome Measures
NameTimeMethod
To determine the hemodynamic consquence of IV Dexmedetomidine and Clonidine administration1min, 2mins, 5mins, 10mins, 15mins, 30mins, 45mins, till end of surgery

Trial Locations

Locations (1)

Obestetrics & Gynaecology Operation Theatre

🇮🇳

Udaipur, RAJASTHAN, India

Obestetrics & Gynaecology Operation Theatre
🇮🇳Udaipur, RAJASTHAN, India
Dr Vikram Bedi
Principal investigator
9829025373
vbedimd@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.